Ever feel like you missed the boat in buying the most successful stocks? Then you’ll want to hear this. On rare occasions, our expert team of analysts issues a “Double Down” stock ...

LISBON, Feb 5 (Reuters) - Novo Banco's planned initial public offering would be beneficial for the Portuguese banking sector, Bank of Portugal Governor Mario Centeno said on Wednesday, but he ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Each of the three Galaxy S25 models delivers cutting-edge features and performance, but which one is right for you? Here’s everything you need to know about Samsung’s latest flagship phones. I ...

Lenovo’s Legion Go S was one of the worst-kept secrets for CES 2025, but now we don’t need to pretend anymore, as we’ve not only seen it in the flesh, but we’ve had enough time to give it ...

These two base flagships are for people who want all the benefits of the proper premium devices without the penalty of a higher price or larger frame. This means that both phones receive silicon ...

Novo Nordisk remains confident in CagriSema’s potential despite underwhelming Phase III results so far. Image credit: Shutterstock/ Kittyfly. Novo Nordisk is planning a new Phase III trial for ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

After hours: February 7 at 7:59:54 PM EST ...